Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

被引：0
|
作者：
R B Egerdie
F Saad
M R Smith
T L J Tammela
J Heracek
P Sieber
C Ke
B Leder
R Dansey
C Goessl
机构：
[1] Urology Associates Urologic Medical Research,Département de Chirurgie
[2] Centre Hospitalier de l’Université de Montréal,Departments of Hematology/Oncology and Medicine
[3] Massachusetts General Hospital Cancer Center,Department of Urology
[4] Tampere University Hospital,undefined
[5] Androgeos,undefined
[6] Urological Associates of Lancaster,undefined
[7] Amgen,undefined
[8] Massachusetts General Hospital Endocrine Unit,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2012年 / 15卷
关键词：
androgen deprivation; bone mineral density; bone loss; antiresorptive therapy; responder analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：308 / 312
页数：4
相关论文
共 50 条
  • [21] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 1012 - 1013
  • [22] Bone health in men receiving androgen deprivation therapy for prostate cancer
    Eastham, James A.
    JOURNAL OF UROLOGY, 2007, 177 (01): : 17 - 24
  • [23] Phase III interim analysis demonstrates toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    Smith, Matthew R.
    Chu, F.
    Forrest, J.
    Malkowicz, S. Bruce
    Price, David
    Sieber, P.
    Barnette, K. G.
    Rodriguez, D.
    Steiner, M. S.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 335 - 335
  • [24] Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy
    Neubecker, Katherine
    Adams-Huet, Beverley
    Farukhi, Irfan M.
    Delapena, Rosinda C.
    Gruntmanis, Ugis
    JOURNAL OF OSTEOPOROSIS, 2011, 2011
  • [25] Rates of bone mineral density measurement in men with prostate cancer starting androgen deprivation therapy
    Suarez-Almazor, Maria
    Peddi, Prashanth
    Luo, Ruili
    Hoang Nguyen
    Elting, Linda S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [26] Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)
    Saad, F.
    Smith, M. R.
    Egerdie, B.
    Tammela, T. L.
    Feldman, R. A.
    Heracek, J.
    Szwedowski, M.
    Ke, C.
    Leder, B.
    Goessl, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer
    Panju, Abbas H.
    Breunis, Henriette
    Cheung, Angela M.
    Leach, Marc
    Fleshner, Neil
    Warde, Padraig
    Duff-Canning, Sarah
    Krahn, Murray
    Naglie, Gary
    Tannock, Ian
    Tomlinson, George
    Alibhai, Shabbir M. H.
    BJU INTERNATIONAL, 2009, 103 (06) : 753 - 757
  • [28] Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy
    Dalla Via, Jack
    Daly, Robin M.
    Owen, Patrick J.
    Mundell, Niamh L.
    Rantalainen, Timo
    Fraser, Steve F.
    BONE, 2019, 127 : 367 - 375
  • [29] The effect of androgen deprivation therapy (ADT) on bone mineral density (BMD) in men with prostate cancer: A meta-analysis
    Lau, A.
    Vinik, O.
    Alibhai, S. M. H.
    Tomlinson, G.
    Cheung, A. M.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S141 - S141
  • [30] Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients
    Deng, JH
    Yang, LP
    Wang, LS
    Zhou, DF
    ASIAN JOURNAL OF ANDROLOGY, 2004, 6 (01) : 75 - 77
12345